Invention Grant
- Patent Title: Treatment of demyelinating diseases
-
Application No.: US16936975Application Date: 2020-07-23
-
Publication No.: US11324742B2Publication Date: 2022-05-10
- Inventor: Thomas Edward Prisinzano , Bronwyn Maree Kivell , Anne Camille La Flamme
- Applicant: Victoria Link Ltd. , University of Kansas
- Applicant Address: NZ Wellington; US KS Lawrence
- Assignee: Victoria Link Ltd.,University of Kansas
- Current Assignee: Victoria Link Ltd.,University of Kansas
- Current Assignee Address: NZ Wellington; US KS Lawrence
- Agency: Fish & Richardson P.C.
- Priority: AU2018900754 20180308
- Main IPC: A61K31/485
- IPC: A61K31/485 ; A61P25/28
Abstract:
The present invention relates generally to methods of using nalfurafine for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing multiple sclerosis (MS). Also disclosed is nalfurafine for use in treating and/or preventing MS as well as pharmaceutical compositions and unit dosage forms comprising nalfurafine for use for treating and/or preventing demyelinating disease in a subject, and in particular for treating and/or preventing MS.
Public/Granted literature
- US20210069179A1 TREATMENT OF DEMYELINATING DISEASES Public/Granted day:2021-03-11
Information query
IPC分类:
